Codagenix retweeted
Can anyone update me on the status of intranasal covid vaccines with mucosal immunity? How can we support researchers with their development and testing? #COVID19 #LongCovid @VirusesImmunity
Codagenix retweeted
#RSV is a common but underappreciated respiratory virus that can lead to serious illness, hospitalization, and death. Learn more at nfid.org/rsv
#PreventRSV
Codagenix retweeted
In the quest to outsmart viral foes such as SARS-CoV-2, RSV & influenza, @Codagenix has engaged a unique arsenal: the intersection of synthetic #biology and #MachineLearning (#ML)
MORE ON THIS HERE: drugdiscoverytrends.com/coda…
#VaccineDevelopment #Vaccine
Codagenix retweeted
The off-season of RSV is the perfect time to learn about the virus before your baby does! RSV spreads when respiratory fluid droplets from an infected person enter the mouth of a healthy individual. #TheMoreYouKnow #edutips
Codagenix retweeted
RSV Infection Might Be Resuming Prepandemic Patterns
pubmed.ncbi.nlm.nih.gov/3707…
Codagenix retweeted
Want to network with the latest #ImmunoOncology experts? Join in virtually or in-person next Tuesday, 5/2 - 5/4, for the @NYASciences Frontiers in Cancer #Immunotherapy Symposium, with Dr. Jeffrey Weber & @theLundLab.
Register here: bit.ly/440fBoy
Codagenix retweeted
On May 2-4, hear from leaders in #Cancer #Immunotherapy Dr. James Allison (@MDAndersonNews), Dr. Nina Bhardwaj (@IcahnMountSinai) and Dr. Robert D. Schreiber (@WUSTLmed) @NYASciences 10th Annual Frontiers in Cancer Immunotherapy symposium. Register: bit.ly/3KUXms0
Codagenix retweeted
#WorldImmunizationWeek2023 campaign aims to raise awareness about the critical importance of full immunization throughout life.
Codagenix retweeted
Replying to @Annja1983
Dieser ⬇️ nasale Impfstoff von Codagenix befindet sich bereits in der Phase-3-Wirksamkeitsstudie. Im besten Fall könnte eine Zulassung bereits im nächsten Jahr erfolgen. 🤞🤞
codagenix.com/codagenix-init…
Codagenix retweeted
Genomic characterization of #RSV during 2022–23 outbreak, Washington, USA, EID journal, bit.ly/3ZKWxqQ
Codagenix retweeted
The actual burden of #RSV among all age groups is likely even higher than estimated due to underreporting of RSV infections. Learn more: nfid.org/rsv
#RSVAwareness #PreventRSV
Codagenix retweeted
.@CNN Health spotlights the efforts of @Codagenix, a company that is leading the new era of live-attenuated vaccine development.
See the article here: cnn.com/2023/04/03/health/na…
#vaccines
Codagenix retweeted
Regulators are considering two highly effective RSV vaccines. What's the holdup? trib.al/H5dHm5A
Codagenix retweeted
The economic burden of RSV infections in low and middle-income countries news-medical.net/news/202304… #RSV #ChildHealth #RespiratorySyncytialVirus #Virology @BMCMedicine @UW @PATHtweets
Codagenix retweeted
#OCUGEN #OCU500 Intranasal vaccination is an attractive strategy for preventing COVID disease as it stimulates the production of multimeric secretory immunoglobulin A (IgAs), the predominant antibody isotype in the mucosal immune system, at the target ... biorxiv.org/content/10.1101/…
Codagenix retweeted
African American women under age 35 have #BreastCancer rates that are higher than white women of the same age. Know your risk and be your own best advocate. bit.ly/3zQnEGJ
Codagenix retweeted
About 1 in 8 women in America will get breast cancer in her lifetime. When found early, #BreastCancer is easier to treat. CDC offers free and low-cost breast cancer screenings to women who have trouble paying for a mammogram. cdc.gov/cancer/nbccedp/scree…
Codagenix retweeted
Interesting! A deep learning model that predicts recurrence and recurrence risk using digital histology and clinical risk factors in patients with #breastcancer.
nature.com/articles/s41523-0…





























